• Something wrong with this record ?

Repeated peripheral administration of lipidized prolactin-releasing peptide analog induces c-fos and FosB expression in neurons of dorsomedial hypothalamic nucleus in male C57 mice

Z. Pirník, M. Kolesárová, B. Železná, L. Maletínská,

. 2018 ; 116 (-) : 77-84. [pub] 20180327

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc19035321

Previous studies indicate that hypothalamic prolactin-releasing peptide (PrRP), signaling via GPR10 and neuropeptide FF2 receptor, is involved in energy homeostasis, stress responses, and cardiovascular regulation. Energy homeostasis depends on the balance between food intake regulation and energy expenditure, in which the hypothalamus plays a key role. The lipidization of PrRP31 with palmitoyl acid allows it to produce its anorexigenic effect after repeated peripheral administration and to reduce body weight and improve metabolic parameters in diet-induced obese (DIO) mice. The aim of this study was to reveal the transient and long-lasting changes in neuronal activity via c-Fos and FosB immunohistochemistry in brain nuclei related to food intake regulation and energy homeostasis during the first days of treatment with a newly designed lipidized analog of PrRP31 (palm11-PrRP31) with promising antiobesity effects. The data revealed that the anorexigenic effect of repeated application of palm11-PrRP31 was associated with delayed but gradually significantly reduced cumulative food intake in mice as well as with a significant reduction in their body weight. Moreover, while the repeated application of palm11-PrRP31 was associated with a significant reduction in acute cell activity in the paraventricular hypothalamic nucleus (PVN) and nucleus of the solitary tract (NTS) compare to its acute treatment, both acute and long-lasting cell activity in the dorsomedial hypothalamic nucleus (DMN) were increased. The data indicate that DMN neurons might be tonically activated after repeated administration of lipidized PrRP analogs that may be associated with the process of long-term adaptation to modified energy homeostasis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035321
003      
CZ-PrNML
005      
20191015124134.0
007      
ta
008      
191007s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.neuint.2018.03.013 $2 doi
035    __
$a (PubMed)29601847
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Pirník, Zdenko $u Institute of Experimental Endocrinology, Biomedical Research Center, SAS, Bratislava, Slovak Republic; Department of Human and Clinical Pharmacology, University of Veterinary Medicine, Košice, Slovak Republic. Electronic address: pirnik@uvm.sk.
245    10
$a Repeated peripheral administration of lipidized prolactin-releasing peptide analog induces c-fos and FosB expression in neurons of dorsomedial hypothalamic nucleus in male C57 mice / $c Z. Pirník, M. Kolesárová, B. Železná, L. Maletínská,
520    9_
$a Previous studies indicate that hypothalamic prolactin-releasing peptide (PrRP), signaling via GPR10 and neuropeptide FF2 receptor, is involved in energy homeostasis, stress responses, and cardiovascular regulation. Energy homeostasis depends on the balance between food intake regulation and energy expenditure, in which the hypothalamus plays a key role. The lipidization of PrRP31 with palmitoyl acid allows it to produce its anorexigenic effect after repeated peripheral administration and to reduce body weight and improve metabolic parameters in diet-induced obese (DIO) mice. The aim of this study was to reveal the transient and long-lasting changes in neuronal activity via c-Fos and FosB immunohistochemistry in brain nuclei related to food intake regulation and energy homeostasis during the first days of treatment with a newly designed lipidized analog of PrRP31 (palm11-PrRP31) with promising antiobesity effects. The data revealed that the anorexigenic effect of repeated application of palm11-PrRP31 was associated with delayed but gradually significantly reduced cumulative food intake in mice as well as with a significant reduction in their body weight. Moreover, while the repeated application of palm11-PrRP31 was associated with a significant reduction in acute cell activity in the paraventricular hypothalamic nucleus (PVN) and nucleus of the solitary tract (NTS) compare to its acute treatment, both acute and long-lasting cell activity in the dorsomedial hypothalamic nucleus (DMN) were increased. The data indicate that DMN neurons might be tonically activated after repeated administration of lipidized PrRP analogs that may be associated with the process of long-term adaptation to modified energy homeostasis.
650    _2
$a zvířata $7 D000818
650    _2
$a tělesná hmotnost $x účinky léků $7 D001835
650    _2
$a nucleus dorsomedialis hypothalami $x účinky léků $x metabolismus $7 D004302
650    _2
$a přijímání potravy $x účinky léků $7 D004435
650    _2
$a energetický metabolismus $7 D004734
650    _2
$a hypothalamus $x účinky léků $x metabolismus $7 D007031
650    _2
$a lipidy $x farmakologie $7 D008055
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a neurony $x metabolismus $7 D009474
650    _2
$a obezita $x farmakoterapie $7 D009765
650    _2
$a hormon uvolňující prolaktin $x metabolismus $x farmakologie $7 D056690
650    _2
$a protoonkogenní proteiny c-fos $x metabolismus $7 D016760
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kolesárová, Mária $u Department of Human and Clinical Pharmacology, University of Veterinary Medicine, Košice, Slovak Republic.
700    1_
$a Železná, Blanka $u Institute of Organic Chemistry and Biochemistry, AS CR, Prague, Czech Republic.
700    1_
$a Maletínská, Lenka $u Institute of Organic Chemistry and Biochemistry, AS CR, Prague, Czech Republic.
773    0_
$w MED00003485 $t Neurochemistry international $x 1872-9754 $g Roč. 116, č. - (2018), s. 77-84
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29601847 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191015124559 $b ABA008
999    __
$a ok $b bmc $g 1451981 $s 1073871
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 116 $c - $d 77-84 $e 20180327 $i 1872-9754 $m Neurochemistry international $n Neurochem Int $x MED00003485
LZP    __
$a Pubmed-20191007

Find record

Citation metrics

Archiving options